Association Between Increased Lipid Profiles and Risk of Diabetic Retinopathy in a Population-Based Case-Control Study

Overview

Journal J Inflamm Res

Publisher Dove Medical Press

Date 2022 Jun 17

PMID 35711238

Authors

Zhenzhen Liu

Mingxi Shao

Jun Ren

Yichao Qiu

Shengjie Li

Wenjun Cao

Affiliations

Soon will be listed here.

Abstract

Purpose: We aimed to investigate the association between lipid profiles and diabetic retinopathy (DR).

Patients And Methods: This case-control study, which was conducted between November 2019 and August 2021, comprised 309 patients with DR, 186 patients with diabetes mellitus, and 172 healthy controls. Serum cholesterol (CHOL), triglyceride (TRIG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), small dense LDL-C (SDLDL-C), apolipoprotein A (APOA), APOB, APOE and lipoprotein (a)(LPA) levels were assessed. Patients were divided into two groups according to median age and glycated hemoglobin (HbA1c) level. Linear and logistic regression analyses were performed to assess the association between lipid levels and DR.

Results: CHOL, TRIG, HDL-C, APOB, APOE, and SDLDL-C levels were significantly higher in the DR group than in the healthy control group, and TRIG levels were lower in the DR group than in the DM group (P < 0.05), especially in the ≤57-year-old and the HbA1c ≤7.2% subgroups. Linear regression analyses showed that CHOL, TRIG, APOA, APOB, APOE, and SDLDL-C levels were associated with HbA1c levels. Multivariable logistic regression analyses indicated that CHOL (odds ratio [OR] = 1.32, 95% confidence interval [CI] = 1.112-1.566), TRIG (OR = 1.269, 95% CI = 1.030-1.563), HDL-C (OR = 43.744, 95% CI = 17.12-111.769), APOB (OR = 7.037, 95% CI = 3.370-14.695), APOE (OR = 1.057, 95% CI = 1.038-1.077), and SDLDL-C (OR = 14.719, 95% CI = 8.304-26.088) levels were risk factors for DR (P < 0.05).

Conclusion: Increased lipid levels were risk factors for DR, and lipid level control should be strengthened, especially in younger adults or in patients with HbA1c ≤7.2%.

Citing Articles

The prevention opportunities of retinopathy in diabetic patients - position paper endorsed by the Polish Lipid Association.

Banach M, Surma S, Dzida G, Jozwiak J, Okopien B, Rysz J Arch Med Sci. 2025; 20(6):1754-1769.

PMID: 39967951 PMC: 11831340. DOI: 10.5114/aoms/197331.

BMI and plasma lipid levels with risk of proliferative diabetic retinopathy: a univariable and multivariable Mendelian randomization study.

Shu Y, Zhou Q, Shao Y, Lin H, Qu S, Han W Front Nutr. 2023; 10:1099807.

PMID: 37771754 PMC: 10524610. DOI: 10.3389/fnut.2023.1099807.

Lipid profiles and their relation to glycemic control in Saudi Arabia: The role of altitudes and environmental factor.

Alqahtani S J Family Med Prim Care. 2023; 12(7):1352-1360.

PMID: 37649774 PMC: 10465043. DOI: 10.4103/jfmpc.jfmpc_104_23.

Cholesterols, Apolipoproteins, and Their Associations with the Presence and Severity of Diabetic Retinopathy: A Systematic Review.

Soedarman S, Kurnia K, Prasetya A, Sasongko M Vision (Basel). 2022; 6(4).

PMID: 36548939 PMC: 9785692. DOI: 10.3390/vision6040077.

References

Siddiqui M, Kennedy G, Carr F, Doney A, Pearson E, Morris A . Lp-PLA activity is associated with increased risk of diabetic retinopathy: a longitudinal disease progression study. Diabetologia. 2018; 61(6):1344-1353. PMC: 6447502. DOI: 10.1007/s00125-018-4601-7. View

Tsuboi H, Tatsumi A, Yamamoto K, Kobayashi F, Shimoi K, Kinae N . Possible connections among job stress, depressive symptoms, lipid modulation and antioxidants. J Affect Disord. 2006; 91(1):63-70. DOI: 10.1016/j.jad.2005.12.010. View

Nakayama A, Morita H, Sato T, Kawahara T, Takeda N, Kato S . Small Dense Low-Density Lipoprotein Cholesterol is a Potential Marker for Predicting Laser Treatment for Retinopathy in Diabetic Patients. J Atheroscler Thromb. 2021; 29(5):678-691. PMC: 9135669. DOI: 10.5551/jat.62889. View

Do D, Wang X, Vedula S, Marrone M, Sleilati G, Hawkins B . Blood pressure control for diabetic retinopathy. Cochrane Database Syst Rev. 2015; 1:CD006127. PMC: 4439213. DOI: 10.1002/14651858.CD006127.pub2. View

Chatziralli I, Sergentanis T, Crosby-Nwaobi R, Winkley K, Eleftheriadis H, Ismail K . Model for Risk-Based Screening of Diabetic Retinopathy in People With Newly-Diagnosed Type 2 Diabetes Mellitus. Invest Ophthalmol Vis Sci. 2017; 58(6):BIO99-BIO105. DOI: 10.1167/iovs.17-21713. View

Kinuthia U, Wolf A, Langmann T . Microglia and Inflammatory Responses in Diabetic Retinopathy. Front Immunol. 2020; 11:564077. PMC: 7681237. DOI: 10.3389/fimmu.2020.564077. View

Semeraro F, Morescalchi F, Cancarini A, Russo A, Rezzola S, Costagliola C . Diabetic retinopathy, a vascular and inflammatory disease: Therapeutic implications. Diabetes Metab. 2019; 45(6):517-527. DOI: 10.1016/j.diabet.2019.04.002. View

Kowluru R, Kowluru A, Mishra M, Kumar B . Oxidative stress and epigenetic modifications in the pathogenesis of diabetic retinopathy. Prog Retin Eye Res. 2015; 48:40-61. PMC: 6697077. DOI: 10.1016/j.preteyeres.2015.05.001. View

Azad N, Bahn G, Emanuele N, Agrawal L, Ge L, Reda D . Association of Blood Glucose Control and Lipids With Diabetic Retinopathy in the Veterans Affairs Diabetes Trial (VADT). Diabetes Care. 2016; 39(5):816-22. DOI: 10.2337/dc15-1897. View

10.

Yan P, Zhao H, Chen X . Suboptimal management of hypertriglyceridemia in the outpatient setting is associated with the recurrent pancreatitis: A retrospective cohort study. Medicine (Baltimore). 2020; 99(43):e22887. PMC: 7581036. DOI: 10.1097/MD.0000000000022887. View

11.

Jorde R, Grimnes G . Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids. Prog Lipid Res. 2011; 50(4):303-12. DOI: 10.1016/j.plipres.2011.05.001. View

12.

Papsdorf K, Brunet A . Linking Lipid Metabolism to Chromatin Regulation in Aging. Trends Cell Biol. 2018; 29(2):97-116. PMC: 6340780. DOI: 10.1016/j.tcb.2018.09.004. View

13.

Santos H, Earnest C, Tinsley G, Izidoro L, Macedo R . Small dense low-density lipoprotein-cholesterol (sdLDL-C): Analysis, effects on cardiovascular endpoints and dietary strategies. Prog Cardiovasc Dis. 2020; 63(4):503-509. DOI: 10.1016/j.pcad.2020.04.009. View

14.

. 2. Classification and Diagnosis of Diabetes: . Diabetes Care. 2019; 43(Suppl 1):S14-S31. DOI: 10.2337/dc20-S002. View

15.

Catalina-Romero C, Calvo E, Sanchez-Chaparro M, Valdivielso P, Sainz J, Cabrera M . The relationship between job stress and dyslipidemia. Scand J Public Health. 2013; 41(2):142-9. DOI: 10.1177/1403494812470400. View

16.

Rezzola S, Corsini M, Chiodelli P, Cancarini A, Nawaz I, Coltrini D . Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy. Diabetologia. 2017; 60(4):719-728. DOI: 10.1007/s00125-016-4204-0. View

17.

Tikhonenko M, Lydic T, Wang Y, Chen W, Opreanu M, Sochacki A . Remodeling of retinal Fatty acids in an animal model of diabetes: a decrease in long-chain polyunsaturated fatty acids is associated with a decrease in fatty acid elongases Elovl2 and Elovl4. Diabetes. 2009; 59(1):219-27. PMC: 2797925. DOI: 10.2337/db09-0728. View

18.

Xu T, Brandmaier S, Messias A, Herder C, Draisma H, Demirkan A . Effects of metformin on metabolite profiles and LDL cholesterol in patients with type 2 diabetes. Diabetes Care. 2015; 38(10):1858-67. DOI: 10.2337/dc15-0658. View

19.

Callaghan B, Xia R, Banerjee M, de Rekeneire N, Harris T, Newman A . Metabolic Syndrome Components Are Associated With Symptomatic Polyneuropathy Independent of Glycemic Status. Diabetes Care. 2016; 39(5):801-7. PMC: 4839175. DOI: 10.2337/dc16-0081. View

20.

van Leiden H, Dekker J, Moll A, Nijpels G, Heine R, Bouter L . Blood pressure, lipids, and obesity are associated with retinopathy: the hoorn study. Diabetes Care. 2002; 25(8):1320-5. DOI: 10.2337/diacare.25.8.1320. View